ODYSSEY to be presented at CROI 2020

Results from the ODYSSEY trial will be presented at this year’s Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, USA. The trial team’s abstract titled “Adequate dolutegravir exposure dosed bid with rifampicin in children 6 to <18 years” has...

Recruitment to the main trial is complete!

Recruitment to the main trial is complete! The ODYSSEY study has reached a major milestone by completing the recruitment of participants to the main trial. Recruitment of children ≥14kg is complete with a total of 707 participants randomised altogether: 311 recruited...